Connect

Stories

• ken 47 none Extended Family Member

  dayton, OH United States

  Here is an amazing product that is in clinical trials to treat TBI and is now being funded with grants from the military thru Virginia Commenwealth Univ. Dr. Speiss is the lead researcher.It has come a long way in it's testing for TBI and has the potential to help many troops recover faster and with better results. Please read for yourself on their website sybd.com My nephew has been to N. Korea and Afghan. and was injured in the line of duty that is why I am passionate about this product. Oxygen Biotherapeutics, Inc., formerly known as Synthetic Blood International, Inc., is dedicated to transforming patient care by developing advanced oxygen-based therapies using Oxycyte®, the company’s perfluorocarbon (PFC) therapeutic oxygen carrier, and other solutions. The company believes Oxycyte has the potential for use in multiple indications, including traumatic brain injury, sickle-cell pain crisis, decompression sickness, stroke, heart attack, and wound treatment. The company estimates that the combined annual incidence for these indications in the United States and Europe is more than 12 million

Comments